Fort Worth-based Sanara MedTech Inc. has announced the appointments of Jake Waldrop as chief operating officer and Tyler Palmer as chief corporate development and strategy officer.
Sanara is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound, and skincare markets.
“Jake and Tyler are seasoned executives with a wealth of experience in the medical device and wound care industries. We are excited for them to join the team and help us continue to build on the success we have had so far, offering solutions that can improve clinical outcomes and reduce healthcare expenditures,” Sanara CEO Zach Fleming said in a statement.
The company said that Waldrop brings 20 years of experience leading cross-functional teams through a multitude of business process transformations in the technology and medical device industries.
Most recently, Waldrop held the position of chief financial officer for Trilliant Surgical, and after their sale to Enovis (formerly DJO) in early 2021, he held the position of vice president of finance and integrations for the newly founded Foot and Ankle division of Enovis.
Waldrop’s career began in public accounting with KPMG, after which he held controller positions at two fast-growing technology companies, The Planet and Alert Logic.
Sanara said that Palmer brings extensive expertise in the healthcare sector, particularly in leading strategic growth and corporate development initiatives aimed at enhancing financial and clinical outcomes for providers, while maximizing shareholder returns.
Most recently, Palmer was the senior vice president of corporate development, strategy, and product at AQuity Solutions, a provider of outsourced revenue cycle and clinical documentation solutions.
There, he crafted and executed a strategic vision that included multiple successful acquisitions and technology investments. Sanara said.
Before that, Palmer held various leadership roles in corporate development, marketing, and business unit leadership across the orthopedic, surgical, and wound care sectors at Zimmer, BSN medical, and Essity.
Waldrop’s appointment is effective April 15, and Palmer’s appointment was effective April 1.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.